Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

MicroRNAs Methylation and Expression Profiling for Identification of Breast Cancer Patients at High Risk to Develop Distant Metastases

NCT06555354 is registered in ClinicalTrials.gov with Casa Sollievo della Sofferenza IRCCS as lead sponsor.

NCT NCT06555354
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06555354 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
MicroRNAs Methylation and Expression Profiling for Identification of Breast Cancer Patients at High Risk to Develop Distant Metastases
Lead sponsor
Casa Sollievo della Sofferenza IRCCS
Phase
Observational
Overall status
Completed
Start date
October 28, 2014
Completion date
November 28, 2019
Enrollment
1,432 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer female, metastases breast